Truttmann Lab

Our overarching goal is to identify and characterize novel mechanisms of proteostasis control which attenuate toxicity in aging-associated disease models to ultimately develop targets for disease-modifying therapies. We are particularly interested in Hsp70 family chaperones and their regulation by post-translational protein modifications (PTMs).